Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Current GLP-1 treatments for obesity consist of daily or weekly injectable medications that come with drawbacks, including the need for cold chain distribution and storage, risk of injection site reactions, and needle-related discomfort
Recalculate your syringe units using the conversion formula
Thevenet, J
To induce weight loss, we employed the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide and the neuropeptide Y receptor Y2 (NPY2R) agonist BI8271, which potentiates GLP-1R-mediated weight loss
Administered as a once-weekly subcutaneous injection, it works by mimicking the effects of natural incretin hormones in the body
These practical strategies help translate dosage knowledge into consistent, accurate practice
US$ 25.88
US$ 26.50
US$ 23.57
US$ 20.46
US$ 26.76
US$ 22.40
US$ 23.12
US$ 22.51
US$ 22.25
US$ 24.73
